. Sprengers, Bumetanide for Core symptoms of Autism Spectrum Disorders (BAMBI): a Single center, double blinded, participant randomized placebo-Controlled, phase two superiority trial, 2020.

. Du, A pilot study on the combination of applied behavioral analysis and bumetanide treatment of children with autism, Journal of child and adolescent Psychopharmacology, pp.585-588, 2015.

. Zhang, Symptom improvement in children with Autism Spectrum Disorder following bumetanide administration is associated with decrease GABA/glutamate ratio, Transl Psychiat, vol.10, p.9, 2020.

. Van-andel, Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open label pilot study, Molecular Autism, vol.11, p.30, 2020.